Scandinavian Biopharma continues to expand and welcomes Erika Söderström as Key Account Manager

Scandinavian Biopharma continues to expand and has recruiting Erika Söderström to the new position as Key Account Manager. Erika is a nurse by education and has for the past 20 years worked in different positions within the vaccine-, pharmaceutical- and medtech-industry.

“Last year we were awarded and qualified as "Gazelle company" by Dagens Industri, DI. This means that we belong to the fastest growing companies in Sweden that are financially profitable with strong financial position. To continue our journey, we need to further strengthen our organization. It is a pleasure to welcome Erika. We have worked together for several years and I know that her profile and solid experience fits us very well ", says Björn Sjöstrand, CEO of Scandinavian Biopharma.

“It feels great to be a part of this exciting and growing company that truly is engaged and focused on vaccines. Vaccination is a global health and development success story, saving millions of lives every year.”, says Erika Söderström.

Ämnen

Kategorier

Scandinavian Biopharma

We are a research-based specialty biopharma company determined to give people worldwide a longer and better life.

We are developing the first vaccine for protection against diarrhoea caused by ETEC in both travellers and endemic populations.

We distribute a wide range of specialty biopharma products with focus on vaccines and immunoglobulins.

www.scandinavianbiopharma.se

Scandinavian Biopharma’s expansion requires expanded premises

We are expanding the business so much that we need larger premises. During the pandemic, the company has hired many new employees in research, clinical development, registration, manufacturing and sales. The space is specially adapted for Scandinavian Biopharma's operations and has a tailor-made, state of the art laboratory with a process development unit as well as a modern meeting place.

Vi är ett forskningsbaserat biotechföretag fast beslutna att ge människor i hela världen ett längre och bättre liv.

Vi utvecklar det första vaccinet i världen mot diarré orsakad av ETEC för att skydda både barn och vuxna i endemiska länder och resenärer till högriskdestinationer.

Vi distribuerar ett brett sortiment av biologiska specialistläkemedel med fokus på vacciner och immunglobuliner.

www.scandinavianbiopharma.se

Vår information på mynewsdesk riktar sig till journalister och media.

Scandinavian Biopharma continues to expand and welcomes Erika Söderström as Key Account Manager

Ämnen

Kategorier

Kontakter

Björn Sjöstrand

Relaterat innehåll

Scandinavian Biopharma’s expansion requires expanded premises

Vi är ett forskningsbaserat biotechföretag fast beslutna att ge människor i hela världen ett längre och bättre liv.

​Scandinavian Biopharma continues to expand and welcomes Erika Söderström as Key Account Manager

Ämnen

Kategorier

Kontakter

Björn Sjöstrand

Relaterat innehåll

Scandinavian Biopharma’s expansion requires expanded premises

Vi är ett forskningsbaserat biotechföretag fast beslutna att ge människor i hela världen ett längre och bättre liv.

Scandinavian Biopharma continues to expand and welcomes Erika Söderström as Key Account Manager